NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets Sep 9, 2025 08:05AM
NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards Jul 16, 2025 05:45PM
NKGen Biotech (NKGN) Selected as Stalking Horse Bidder for NKMax Dec 2, 2024 04:08PM
NKGen Biotech Selected as Stalking Horse Bidder for NKMax Dec 2, 2024 04:05PM
NKGen Biotech (NKGN) Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel Nov 26, 2024 04:19PM


Nov 26, 2024 04:15PM NKGen Biotech Receives Notifications From Nasdaq Related to Delayed Quarterly Report and Decision of the Nasdaq Hearings Panel